Eli Lilly Corp. buy Guggenheim
Start price
11.07.25
/
50%
€672.80
Target price
11.07.26
€806.82
Performance (%)
-1.07%
Price
30.07.25
€665.60
Summary
This prediction is currently active. With a performance of -1.07%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 11.07.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Eli Lilly Corp. | -1.945% |
| iShares Core DAX® | -1.184% |
| iShares Nasdaq 100 | 3.941% |
| iShares Nikkei 225® | -1.206% |
| iShares S&P 500 | 3.141% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Guggenheim from $936.00 to $942.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-20.84%
30.07.25
30.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€706.60
05.08.24
05.08.24
€806.83
05.08.25
05.08.25
-5.26%
30.07.25
30.07.25